Yellowstone Biosciences
London, United Kingdom· Est. 2017
Yellowstone aims to unlock a new class of therapeutically targetable frequently expressed antigens with potential to significantly transform patient lives.
Private Company
Funding information not available
About
Yellowstone aims to unlock a new class of therapeutically targetable frequently expressed antigens with potential to significantly transform patient lives.
Biologics